Literature DB >> 10877081

Experience with Bailey-Dubow rodding in children with osteogenesis imperfecta.

A Karbowski1, M Schwitalle, R Brenner, H Lehmann, B Pontz, O Wörsdörfer.   

Abstract

AIM: The current report presents our experience with the use of Bailey-Dubow elongation rods in children with osteogenesis imperfecta.
MATERIAL AND METHODS: 63 patients with osteogenesis imperfecta underwent a total of 186 primary intramedullary fixations with Bailey-Dubow rods during period 1984-1996. Most of them were inserted into the femur (54.3 %), followed by the tibia (38.2%) and the humerus (7.9%). Patients' age at operation ranged from 1-12 years and treatment-period varied from 1-10 years.
RESULTS: Insertion into the femur showed the lowest complication rate (21.0%). Patients either suffered from knee-joint migration of the distal nail (3.9%), proximal nail migration (7.9%), detached T-pieces from the sleeve (7.9%) or chronical nail infection (1.0%). Complication rate after tibia rodding was markedly higher (52.1%). Knee joint migration appeared in 8.5% and the distal piece of the rod migrated proximally in 38.0%, in 31.0% accompanied by recurrent antecurve deformity. Growth arrest and no elongation occurred in 5.6%. Results after humerus operation were by far least satisfying. None of the nails elongated adequately. 8 of the 14 Bailey-Dubow rods (57.1 %) required reoperation caused by migration and chronic nail infection, whereas reoperation rates amounted to 17.8% after femur and 29.6% after tibia insertion. However, just one refracture happened after adequate trauma (road accident), so that an extraordinary success of fracture prevention has to be scored.
CONCLUSIONS: We concluded that the use of Bailey-Dubow rods in early childhood can be recommended for the femur, whereas insertion into the tibia or humerus is associated with a considerable complication rate.

Entities:  

Mesh:

Year:  2000        PMID: 10877081     DOI: 10.1055/s-2008-1072339

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  9 in total

1.  [Osteogenesis imperfecta].

Authors:  M Salzmann; C Krohn; N Berger
Journal:  Orthopade       Date:  2014-08       Impact factor: 1.087

Review 2.  Osteogenesis imperfecta: pathophysiology and treatment.

Authors:  Heike Hoyer-Kuhn; Christian Netzer; Oliver Semler
Journal:  Wien Med Wochenschr       Date:  2015-06-09

3.  A Novel, Low-Cost Telescopic Nail Design for Prevention and Treatment of Osteogenesis Imperfecta Associated Long-Bone Pathological Fractures in Children.

Authors:  Karthick Rangasamy; Pebam Sudesh; Nirmal Raj Gopinathan; Santosh Behera
Journal:  Indian J Orthop       Date:  2022-03-14       Impact factor: 1.033

4.  Management pitfalls of fractured neck of femur in osteogenesis imperfecta.

Authors:  Wang Chow; Rajiv Negandhi; Evelyn Kuong; Michael To
Journal:  J Child Orthop       Date:  2013-03-29       Impact factor: 1.548

5.  [Diagnosis and therapy of osteogenesis imperfecta].

Authors:  A Meurer; T Lewens; D Schmitt; T Vetter; P Drees
Journal:  Orthopade       Date:  2008-01       Impact factor: 1.087

6.  [Osteogenesis imperfecta].

Authors:  T Wirth
Journal:  Orthopade       Date:  2012-09       Impact factor: 1.087

Review 7.  Pain Phenotypes in Rare Musculoskeletal and Neuromuscular Diseases.

Authors:  Anthony Tucker-Bartley; Jordan Lemme; Andrea Gomez-Morad; Nehal Shah; Miranda Veliu; Frank Birklein; Claudia Storz; Seward Rutkove; David Kronn; Alison M Boyce; Eduard Kraft; Jaymin Upadhyay
Journal:  Neurosci Biobehav Rev       Date:  2021-02-10       Impact factor: 9.052

Review 8.  The orthopaedic management of long bone deformities in genetically and acquired generalized bone weakening conditions.

Authors:  T Wirth
Journal:  J Child Orthop       Date:  2019-02-01       Impact factor: 1.548

9.  Early telescopic rod osteosynthesis for Osteogenesis Imperfecta patients.

Authors:  A Sterian; R Balanescu; A Barbilian; I Tevanov; M Carp; C Nahoi; M Barbu; A Ulici
Journal:  J Med Life       Date:  2015 Oct-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.